AdvanDx Obtains $12,000,000 Series B Financing Round

  • Feed Type
  • Date
    4/9/2014
  • Company Name
    AdvanDx
  • Mailing Address
    400 TradeCenter Woburn, MA 01801 USA
  • Company Description
    AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available in hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations.
  • Website
    http://www.advandx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The Series B-1 financing will be used to fund the expansion of AdvanDx’s molecular diagnostic product offerings, as well as its sales and marketing presence in the U.S. and internationally.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor